Bioquell superbug eradication technology upgraded

Bioquell has revealed that its "superbug" eradication technology has been upgraded by the Department of Health’s Rapid Review Panel (RRP) to category one status.

Set up by the government in 2004, the RRP facilitates the rapid review of products and technologies potentially able to combat hospital-acquired infections, or "superbugs", by an independent panel of leading UK infection control experts.

Bioquell’s hydrogen peroxide vapour (HPV) decontamination technology was one of the first technologies to be reviewed by the RRP, which it awarded category two status after a review of the scientific data available.

Achieving category one status denotes, according to the RRP, that "basic research and development, validation and recent in use evaluations have shown benefits that should be available to NHS bodies to include as appropriate in their cleaning, hygiene or infection control protocol."

Nick Adams, chief executive of Bioquell, commented: "Clostridium difficile, MRSA and other ‘superbugs’ remain a real, increasing and sensitive problem for hospitals in the NHS and around the world.

"Despite the sensitivity of these problems, we are pleased that Bioquell is being asked to help more and more NHS hospitals combat Clostridium difficile."

Bioquell is the UK leader in specialist decontamination technology and testing services.